Internal mammary nodes in breast cancer: Diagnosis and implications for patient management - A systematic review

Journal of Clinical Oncology

Volumn 26, Issue 30, 2008, Pages 4981-4989

  Chen, Ronald C ^a   Lin, Nancy U ^a   Golshan, Mehra ^a   Harris, Jay R ^a   Bellon, Jennifer R ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRACYCLINE; CYCLOPHOSPHAMIDE; DOXORUBICIN; FLUOROURACIL; METHOTREXATE; MITOMYCIN; TAMOXIFEN; TRASTUZUMAB;

ADVERSE OUTCOME; AXILLARY LYMPH NODE; BREAST CANCER; CANCER COMBINATION CHEMOTHERAPY; CANCER CONTROL; CANCER HORMONE THERAPY; CANCER LOCALIZATION; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURVIVAL; CARDIOTOXICITY; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; DIAGNOSTIC VALUE; HIGH RISK PATIENT; HUMAN; INCIDENCE; INTERMETHOD COMPARISON; INTERNAL MAMMARY NODE; LYMPH NODE; LYMPH NODE BIOPSY; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; LYMPHOSCINTIGRAPHY; MASTECTOMY; MORBIDITY; PATIENT CARE; PRIORITY JOURNAL; PROGNOSIS; RADIATION INJURY; REVIEW; SENTINEL LYMPH NODE; SURVIVAL RATE; SURVIVAL TIME; SYSTEMATIC REVIEW; SYSTEMIC THERAPY; THERAPY EFFECT; TUMOR BIOPSY; ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; BREAST TUMOR; CARDIOVASCULAR DISEASE; FEMALE; METHODOLOGY; MORTALITY; RADIOTHERAPY; SCINTISCANNING; SENTINEL LYMPH NODE BIOPSY; TUMOR RECURRENCE;

BREAST NEOPLASMS; CARDIOVASCULAR DISEASES; CHEMOTHERAPY, ADJUVANT; FEMALE; HUMANS; LYMPH NODES; LYMPHATIC IRRADIATION; LYMPHATIC METASTASIS; MASTECTOMY, EXTENDED RADICAL; NEOPLASM RECURRENCE, LOCAL; RADIOTHERAPY, ADJUVANT; SENTINEL LYMPH NODE BIOPSY; SURVIVAL RATE;

EID: 54449096802     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2008.17.4862     Document Type: Review

References (88)

1. National Comprehensive Cancer Network: NCCN Breast Cancer Clinical Practice Guidelines in Oncology (V. 2.2008). http://www.nccn.org/professionals/ physician_gls/PDF/breast.pdf
2. Buzdar AU, McNeese MD, Hortobagyi GN, et al: Is chemotherapy effective in reducing the local failure rate in patients with operable breast cancer? Cancer 65:394-399, 1990
3. Galper S, Recht A, Silver B, et al: Factors associated with regional nodal failure in patients with early stage breast cancer with 0-3 positive axillary nodes following tangential irradiation alone. Int J Radiat Oncol Biol Phys 45:1157-1166, 1999
4. Recht A, Gray R, Davidson NE, et al: Locoregional failure 10 years after mastectomy and adjuvant chemotherapy with or without tamoxifen without irradiation: Experience of the Eastern Cooperative Oncology Group. J Clin Oncol 17:1689-1700, 1999
5. Stefanik D, Goldberg R, Byrne P, et al: Local-regional failure in patients treated with adjuvant chemotherapy for breast cancer. J Clin Oncol 3:660-665, 1985
6. Overgaard M, Hansen PS, Overgaard J, et al: Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy: Danish Breast Cancer Cooperative Group 82b Trial. N Engl J Med 337:949-955, 1997
7. Overgaard M, Jensen MB, Overgaard J, et al: Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomised trial. Lancet 353:1641-1648, 1999
8. Ragaz J, Olivotto IA, Spinelli JJ, et al: Locoregional radiation therapy in patients with high-risk breast cancer receiving adjuvant chemotherapy: 20-year results of the British Columbia randomized trial. J Natl Cancer Inst 97:116-126, 2005
9. Clarke M, Collins R, Darby S, et al: Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: An overview of the randomised trials. Lancet 366:2087-2106, 2005
10. Kroman N, Wohlfahrt J, Mouridsen HT, et al: Influence of tumor location on breast cancer prognosis. Int J Cancer 105:542-545, 2003
11. Lohrisch C, Jackson J, Jones A, et al: Relationship between tumor location and relapse in 6,781 women with early invasive breast cancer. J Clin Oncol 18:2828-2835, 2000
12. Zucali R, Mariani L, Marubini E, et al: Early breast cancer: Evaluation of the prognostic role of the site of the primary tumor. J Clin Oncol 16:1363-1366, 1998
13. Gaffney DK, Tsodikov A, Wiggins CL: Diminished survival in patients with inner versus outer quadrant breast cancers. J Clin Oncol 21:467-472, 2003
14. Colleoni M, Zahrieh D, Gelber RD, et al: Site of primary tumor has a prognostic role in operable breast cancer: The International Breast Cancer Study Group experience. J Clin Oncol 23:1390-1400, 2005
15. Sarp S, Fioretta G, Verkooijen HM, et al: Tumor location of the lower-inner quadrant is associated with an impaired survival for women with early-stage breast cancer. Ann Surg Oncol 14:1031-1039, 2007
16. Veronesi U, Cascinelli N, Greco M, et al: Prognosis of breast cancer patients after mastectomy and dissection of internal mammary nodes. Ann Surg 202:702-707, 1985
17. Donegan WL: The influence of untreated internal mammary metastases upon the course of mammary cancer. Cancer 39:533-538, 1977
18. Handley RS, Thackray AC: Invasion of internal mammary lymph nodes in carcinoma of the breast. BMJ 1:61-63, 1954
19. Handley RS, Patey DH, Hand BH: Excision of the internal mammary chain in radical mastectomy: Results in 57 cases. Lancet 270:457-461, 1956
20. Caceres E: Incidence of metastasis in the internal mammary chain in operable carcinoma of the breast and 5 year results. Acta Unio Int Contra Cancrum 19:1566-1569, 1963
21. Handley RS: Carcinoma of the breast. Ann R Coll Surg Engl 57:59-66, 1975
22. Lacour J, Bucalossi P, Cacers E, et al: Radical mastectomy versus radical mastectomy plus internal mammary dissection: Five-year results of an international cooperative study. Cancer 37:206-214, 1976
23. Livingston SF, Arlen M: The extended extrapleural radical mastectomy: Its role in the treatment of carcinoma of the breast. Ann Surg 179:260-265, 1974
24. Urban JA, Marjani MA: Significance of internal mammary lymph node metastases in breast cancer. Am J Roentgenol Radium Ther Nucl Med 111:130-136, 1971
25. Huang O, Wang L, Shen K, et al: Breast cancer subpopulation with high risk of internal mammary lymph nodes metastasis: Analysis of 2,269 Chinese breast cancer patients treated with extended radical mastectomy. Breast Cancer Res Treat 107:379-387, 2008
26. Sugg SL, Ferguson DJ, Posner MC, et al: Should internal mammary nodes be sampled in the sentinel lymph node era? Ann Surg Oncol 7:188-192, 2000
27. Dahl-Iversen E, Tobiassen T: Radical mastectomy with parasternal and supraclavicular dissection for mammary carcinoma. Ann Surg 170:889-891, 1969
28. Urban JA: Management of operable breast cancer: The surgeon's view. Cancer 42:2066-2077, 1978
29. Lacour J, Le MG, Hill C, et al: Is it useful to remove internal mammary nodes in operable breast cancer? Eur J Surg Oncol 13:309-314, 1987
30. Lacour J, Le M, Caceres E, et al: Radical mastectomy versus radical mastectomy plus internal mammary dissection: Ten year results of an international cooperative trial in breast cancer. Cancer 51:1941-1943, 1983
31. Veronesi U, Valagussa P: Inefficacy of internal mammary nodes dissection in breast cancer surgery. Cancer 47:170-175, 1981
32. Meier P, Ferguson DJ, Karrison T: A controlled trial of extended radical versus radical mastectomy: Ten-year results. Cancer 63:188-195, 1989
33. Morimoto T, Monden Y, Takashima S, et al: Five-year results of a randomized clinical trial comparing modified radical mastectomy and extended radical mastectomy for stage II breast cancer. Surg Today 24:210-214, 1994
34. Veronesi U, Marubini E, Mariani L, et al: The dissection of internal mammary nodes does not improve the survival of breast cancer patients: 30-year results of a randomised trial. Eur J Cancer 35:1320-1325, 1999
35. Meier P, Ferguson DJ, Karrison T: A controlled trial of extended radical mastectomy. Cancer 55:880-891, 1985
36. Madsen E, Gobardhan P, Bongers V, et al: The impact on post-surgical treatment of sentinel lymph node biopsy of internal mammary lymph nodes in patients with breast cancer. Ann Surg Oncol 14:1486-1492, 2007
37. Paredes P, Vidal-Sicart S, Zanon G, et al: Clinical relevance of sentinel lymph nodes in the internal mammary chain in breast cancer patients. Eur J Nucl Med Mol Imaging 32:1283-1287, 2005
38. Park C, Seid P, Morita E, et al: Internal mammary sentinel lymph node mapping for invasive breast cancer: Implications for staging and treatment. Breast J 11:29-33, 2005
39. Benda RK, Cendan JC, Copeland EM, et al: Should decisions on internal mammary lymph node irradiation be based on current lymphoscintigraphy techniques for sentinel lymph node identification? Cancer 100:518-523, 2004
40. Shimazu K, Tamaki Y, Taguchi T, et al: Lymphoscintigraphic visualization of internal mammary nodes with subtumoral injection of radiocolloid in patients with breast cancer. Ann Surg 237:390-398, 2003
41. Paganelli G, Galimberti V, Trifiro G, et al: Internal mammary node lymphoscintigraphy and biopsy in breast cancer. Q J Nucl Med 46:138-144, 2002
42. Roumen RM, Geuskens LM, Valkenburg JG: In search of the true sentinel node by different injection techniques in breast cancer patients. Eur J Surg Oncol 25:347-351, 1999
43. Farrús B, Vidal-Sicart S, Velasco M, et al: Incidence of internal mammary node metastases after a sentinel lymph node technique in breast cancer and its implication in the radiotherapy plan. Int J Radiat Oncol Biol Phys 60:715-721, 2004
44. Estourgie SH, Nieweg OE, Olmos RA, et al: Lymphatic drainage patterns from the breast. Ann Surg 239:232-237, 2004
45. Carcoforo P, Sortini D, Feggi L, et al: Clinical and therapeutic importance of sentinel node biopsy of the internal mammary chain in patients with breast cancer: A single-center study with long-term follow-up. Ann Surg Oncol 13:1338-1343, 2006
46. Lamonica D, Edge SB, Hurd T, et al: Mammographic and clinical predictors of drainage patterns in breast lymphoscintigrams obtained during sentinel node procedures. Clin Nucl Med 28:558-564, 2003
47. van der Ent FW, Kengen RA, van der Pol HA, et al: Halsted revisited: Internal mammary sentinel lymph node biopsy in breast cancer. Ann Surg 234:79-84, 2001
48. Byrd DR, Dunnwald LK, Mankoff DA, et al: Internal mammary lymph node drainage patterns in patients with breast cancer documented by breast lymphoscintigraphy. Ann Surg Oncol 8:234-240, 2001
49. Shahar KH, Buchholz TA, Delpassand E, et al: Lower and central tumor location correlates with lymphoscintigraphy drainage to the internal mammary lymph nodes in breast carcinoma. Cancer 103:1323-1329, 2005
50. Chagpar AB, Kehdy F, Scoggins CR, et al: Effect of lymphoscintigraphy drainage patterns on sentinel lymph node biopsy in patients with breast cancer. Am J Surg 190:557-562, 2005
51. Dupont E, Cox CE, Nguyen K, et al: Utility of internal mammary lymph node removal when noted by intraoperative gamma probe detection. Ann Surg Oncol 8:833-836, 2001
52. Dupont EL, Salud CJ, Peltz ES, et al: Clinical relevance of internal mammary node mapping as a guide to radiation therapy. Am J Surg 182:321-324, 2001
53. Galimberti V, Veronesi P, Arnone P, et al: Stage migration after biopsy of internal mammary chain lymph nodes in breast cancer patients. Ann Surg Oncol 9:924-928, 2002
54. Hong J, Choy E, Soni N, et al: Extra-axillary sentinel node biopsy in the management of early breast cancer. Eur J Surg Oncol 31:942-948, 2005
55. Jansen L, Doting MH, Rutgers EJ, et al: Clinical relevance of sentinel lymph nodes outside the axilla in patients with breast cancer. Br J Surg 87:920-925, 2000
56. Johnson N, Soot L, Nelson J, et al: Sentinel node biopsy and internal mammary lymphatic mapping in breast cancer. Am J Surg 179:386-388, 2000
57. Estourgie SH, Tanis PJ, Nieweg OE, et al: Should the hunt for internal mammary chain sentinel nodes begin? An evaluation of 150 breast cancer patients. Ann Surg Oncol 10:935-941, 2003
58. Uren RF, Howman-Giles RB, Thompson JF, et al: Mammary lymphoscintigraphy in breast cancer. J Nucl Med 36:1775-1780, 1995
59. Ragaz J, Jackson SM, Le N, et al: Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer. N Engl J Med 337:956-962, 1997
60. Punglia RS, Morrow M, Winer EP, et al: Local therapy and survival in breast cancer. N Engl J Med 356:2399-2405, 2007
61. Fowble B, Hanlon A, Freedman G, et al: Internal mammary node irradiation neither decreases distant metastases nor improves survival in stage I and II breast cancer. Int J Radiat Oncol Biol Phys 47:883-894, 2000
62. Le MG, Arriagada R, de Vathaire F, et al: Can internal mammary chain treatment decrease the risk of death for patients with medial breast cancers and positive axillary lymph nodes? Cancer 66:2313-2318, 1990
63. Obedian E, Haffty BG: Internal mammary nodal irradiation in conservatively-managed breast cancer patients: Is there a benefit? Int J Radiat Oncol Biol Phys 44:997-1003, 1999
64. Arriagada R, Le MG, Mouriesse H, et al: Long-term effect of internal mammary chain treatment: Results of a multivariate analysis of 1195 patients with operable breast cancer and positive axillary nodes. Radiother Oncol 11:213-222, 1988
65. Fowble B, Glick J, Goodman R: Radiotherapy for the prevention of local-regional recurrence in high risk patients post mastectomy receiving adjuvant chemotherapy. Int J Radiat Oncol Biol Phys 15:627-631, 1988
66. Stemmer SM, Rizel S, Hardan I, et al: The role of irradiation of the internal mammary lymph nodes in high-risk stage II to IIIA breast cancer patients after high-dose chemotherapy: A prospective sequential nonrandomized study. J Clin Oncol 21:2713-2718, 2003
67. Fabry HF, Mutsaers PG, Meijer S, et al: Clinical relevance of parasternal uptake in sentinel node procedure for breast cancer. J Surg Oncol 87:13-18, 2004
68. Eubank WB, Mankoff DA, Takasugi J, et al: 18Fluorodeoxyglucose positron emission tomography to detect mediastinal or internal mammary metastases in breast cancer. J Clin Oncol 19:3516-3523, 2001
69. Kaija H, Maunu P: Tangential breast irradiation with or without internal mammary chain irradiation: Results of a randomized trial. Radiother Oncol 36:172-176, 1995
70. Romestaing P, Ecochar R, Hennequin C, et al: Role of internal mammary chain irradiation on survival after mastectomy for breast cancer: Results of a phase III SFRO trial. Radiother Oncol 56:306, 2000 (abstr)
71. Poortmans PM, Venselaar JL, Struikmans H, et al: The potential impact of treatment variations on the results of radiotherapy of the internal mammary lymph node chain: A quality-assurance report on the dummy run of EORTC phase III randomized trial 22922/10925 in stage I-III breast cancer. Int J Radiat Oncol Biol Phys 49:1399-1408, 2001
72. Olivotto IA, Chua B, Elliott EA, et al: A clinical trial of breast radiation therapy versus breast plus regional radiation therapy in early-stage breast cancer: The MA20 trial. Clin Breast Cancer 4:361-363, 2003
73. Darby SC, McGale P, Taylor CW, et al: Long-term mortality from heart disease and lung cancer after radiotherapy for early breast cancer: Prospective cohort study of about 300,000 women in US SEER cancer registries. Lancet Oncol 6:557-565, 2005
74. Giordano SH, Kuo YF, Freeman JL, et al: Risk of cardiac death after adjuvant radiotherapy for breast cancer. J Natl Cancer Inst 97:419-424, 2005
75. Taylor CW, Nisbet A, McGale P, et al: Cardiac exposures in breast cancer radiotherapy: 1950s-1990s. Int J Radiat Oncol Biol Phys 69:1484-1495, 2007
76. Paszat LF, Vallis KA, Benk VM, et al: A population-based case-cohort study of the risk of myocardial infarction following radiation therapy for breast cancer. Radiother Oncol 82:294-300, 2007
77. Hooning MJ, Botma A, Aleman BM, et al: Long-term risk of cardiovascular disease in 10-year survivors of breast cancer. J Natl Cancer Inst 99:365-375, 2007
78. Gagliardi G, Lax I, Soderstrom S, et al: Prediction of excess risk of long-term cardiac mortality after radiotherapy of stage I breast cancer. Radiother Oncol 46:63-71, 1998
79. Lind PA, Pagnanelli R, Marks LB, et al: Myocardial perfusion changes in patients irradiated for left-sided breast cancer and correlation with coronary artery distribution. Int J Radiat Oncol Biol Phys 55:914-920, 2003
80. Storey MR, Munden R, Strom EA, et al: Coronary artery dosimetry in intact left breast irradiation. Cancer J 7:492-497, 2001
81. Arthur DW, Arnfield MR, Warwicke LA, et al: Internal mammary node coverage: An investigation of presently accepted techniques. Int J Radiat Oncol Biol Phys 48:139-146, 2000
82. Pierce LJ, Butler JB, Martel MK, et al: Postmastectomy radiotherapy of the chest wall: Dosimetric comparison of common techniques. Int J Radiat Oncol Biol Phys 52:1220-1230, 2002
83. Jensen BV: Cardiotoxic consequences of anthracycline-containing therapy in patients with breast cancer. Semin Oncol 33:S15-S21, 2006 (suppl)
84. Telli ML, Hunt SA, Carlson RW, et al: Trastuzumab-related cardiotoxicity: Calling into question the concept of reversibility. J Clin Oncol 25:3525-3533, 2007
85. Taghian A, Jagsi R, Makris A, et al: Results of a survey regarding irradiation of internal mammary chain in patients with breast cancer: Practice is culture driven rather than evidence based. Int J Radiat Oncol Biol Phys 60:706-714, 2004
86. Singletary SE, Allred C, Ashley P, et al: Revision of the American Joint Committee on Cancer staging system for breast cancer. J Clin Oncol 20:3628-3636, 2002
87. Skandarajah AR, Tjandra JJ: Preoperative loco-regional imaging in rectal cancer. ANZ J Surg 76:497-504, 2006
88. Koyama T, Tamai K, Togashi K: Staging of carcinoma of the uterine cervix and endometrium. Eur Radiol 17:2009-2019, 2007